Achieve Life Sciences Inc (ACHV)
5.00
-0.07
(-1.38%)
USD |
NASDAQ |
May 17, 16:00
4.99
-0.01
(-0.20%)
After-Hours: 20:00
Achieve Life Sciences Net Income (Quarterly): -6.494M for March 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -6.494M |
| December 31, 2023 | -5.476M |
| September 30, 2023 | -7.108M |
| June 30, 2023 | -8.239M |
| March 31, 2023 | -8.992M |
| December 31, 2022 | -11.23M |
| September 30, 2022 | -13.08M |
| June 30, 2022 | -10.47M |
| March 31, 2022 | -7.573M |
| December 31, 2021 | -7.151M |
| September 30, 2021 | -6.691M |
| June 30, 2021 | -11.31M |
| March 31, 2021 | -7.999M |
| December 31, 2020 | -4.724M |
| September 30, 2020 | -3.764M |
| June 30, 2020 | -2.922M |
| March 31, 2020 | -3.32M |
| December 31, 2019 | -3.194M |
| September 30, 2019 | -3.673M |
| June 30, 2019 | -3.624M |
| March 31, 2019 | -5.904M |
| December 31, 2018 | -3.637M |
| September 30, 2018 | -3.24M |
| June 30, 2018 | -2.788M |
| March 31, 2018 | -3.022M |
| Date | Value |
|---|---|
| December 31, 2017 | -3.74M |
| September 30, 2017 | -6.472M |
| June 30, 2017 | -0.166M |
| March 31, 2017 | -0.205M |
| December 31, 2016 | 13.05M |
| September 30, 2016 | -3.69M |
| June 30, 2016 | -6.889M |
| March 31, 2016 | -3.707M |
| December 31, 2015 | -1.724M |
| September 30, 2015 | -4.55M |
| June 30, 2015 | -6.01M |
| March 31, 2015 | -4.517M |
| December 31, 2014 | -5.681M |
| September 30, 2014 | -4.907M |
| June 30, 2014 | -7.015M |
| March 31, 2014 | -8.636M |
| December 31, 2013 | -6.678M |
| September 30, 2013 | -10.05M |
| June 30, 2013 | -8.42M |
| March 31, 2013 | -6.697M |
| December 31, 2012 | -4.103M |
| September 30, 2012 | -5.92M |
| June 30, 2012 | -4.215M |
| March 31, 2012 | -6.86M |
| December 31, 2011 | -9.569M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-13.08M
Minimum
Sep 2022
-2.922M
Maximum
Jun 2020
-6.852M
Average
-6.900M
Median
Net Income (Quarterly) Benchmarks
| Accelerate Diagnostics Inc | -14.23M |
| Atossa Therapeutics Inc | -5.878M |
| ENDRA Life Sciences Inc | -2.776M |
| Perspective Therapeutics Inc | -12.28M |
| Electromed Inc | 1.493M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 5.982M |
| EPS Diluted (Quarterly) | -0.26 |
| Enterprise Value | 122.45M |
| Earnings Yield | -25.40% |
| Normalized Earnings Yield | -29174.24 |